Fournelle M, Tretbar S
Fraunhofer Institut für Biomedizinische Technik IBMT, Ensheimer Str. 48, 66386, St. Ingbert, Deutschland.
Radiologe. 2015 Nov;55(11):964-6, 968-75. doi: 10.1007/s00117-015-0024-3.
CLINICAL/METHODICAL ISSUE: Imaging modalities play an increasing role in today's medical diagnostics. Among them, ultrasound (US) is one the most widespread techniques although it has relatively poor soft tissue contrast. Furthermore, US is poorly suited as a modality for molecular imaging (MI).
Methods such as Doppler and contrast-enhanced US (CEUS) allow functional imaging of the vasculature; however, ultrasound-based MI remains limited to the vascular network due to the size of available contrast agents.
Optoacoustic imaging combines the benefits of optics (high contrast) with those of acoustics (low scattering and high resolution). In this technique, signals are generated in tissue with high contrast depending on the local optical absorption coefficient and detected with an acoustic procedure.
Optoacoustic imaging can intrinsically be scaled in terms of resolution and is therefore usable in various applications from in vitro microscopy, to preclinical small animal imaging up to clinical imaging. With a resolution in the range of clinical ultrasound systems (100-400 µm), highly scattering tissue can be imaged up to several centimeters in depth.
In contrast to conventional ultrasound imaging, optoacoustic techniques are highly suitable for MI. Various contrast agents as well as different technical implementations of the approach have already been preclinically evaluated. The technique is currently close to being transferred to clinical implementation and the first studies have already been started.
Clinical studies are ongoing with respect to early diagnosis of breast cancer and arthritis. Furthermore, the suitability of the technique for skin imaging is currently being investigated.
临床/方法学问题:成像方式在当今医学诊断中发挥着越来越重要的作用。其中,超声(US)是应用最广泛的技术之一,尽管其软组织对比度相对较差。此外,超声不太适合作为分子成像(MI)的方式。
诸如多普勒超声和超声造影(CEUS)等方法可实现血管系统的功能成像;然而,由于可用造影剂的大小,基于超声的分子成像仍局限于血管网络。
光声成像结合了光学(高对比度)和声学(低散射和高分辨率)的优点。在这种技术中,根据局部光吸收系数在组织中产生具有高对比度的信号,并通过声学方法进行检测。
光声成像在分辨率方面本质上是可扩展的,因此可用于从体外显微镜检查到临床前小动物成像直至临床成像的各种应用。在临床超声系统的分辨率范围内(100 - 400微米),可以对深度达几厘米的高散射组织进行成像。
与传统超声成像相比,光声技术非常适合分子成像。各种造影剂以及该方法的不同技术实施方案已经在临床前进行了评估。该技术目前已接近转化为临床应用,并且已经开始了首批研究。
关于乳腺癌和关节炎的早期诊断正在进行临床研究。此外,目前正在研究该技术对皮肤成像的适用性。